BiotechTube
Home/Reglagene/Lawrence Kinet, MBA
LK

Lawrence Kinet, MBA

Board Chair

Reglagene

Therapeutic Areas

OncologyNeurology

Reglagene Pipeline

DrugIndicationPhase
RGN6024Brain Cancers (e.g., Glioblastoma)Pre-clinical

Leadership Team at Reglagene

RA
Richard Austin, PhD, MBA
Chief Executive Officer/President
VG
Vijay Gokhale, PhD
Senior Vice President, Preclinical Development
LH
Laurence Hurley, PhD
Director, Co-Founder
View full Reglagene profile